Kymera Discloses New KT-474 Clinical Data, Unveils New Devel

Kymera Discloses New KT-474 Clinical Data, Unveils New Development Program, Provides Oncology Pipeline as well as Platform and Discovery Updates, and Outlines 5-year Vision and Goals at 2021 R&D Day

Related Keywords

Boston , Massachusetts , United States , Watertown , Ikaros Aiolos , Cereblon Imi , Nello Mainolfi , A Alpha Bio , I Kymera Therapeutics Inc , University Of Washington , Development Program , York University , Nasdaq , Kymera Discloses New , Unveils New Development Program , Provides Oncology Pipeline , Discovery Updates , Ascending Dose , United Statesi December , Kymera Therapeutics , Chief Executive , Portfolio Updates , Diffuse Largeb Cell Lymphoma , New York , Fierce Biotech , Boston Business Journal , Small Molecule , New Chemical Entity , Ice , Chemistry , Mural , Inhaled , Drug Delivery , Depot , Flow Release ,